Article Text

Download PDFPDF

Impact of malnutrition on survival and healthcare utilization in Medicare beneficiaries with diabetes: a retrospective cohort analysis
  1. Naseer Ahmed1,
  2. Yong Choe1,
  3. Vikkie A Mustad1,
  4. Sumita Chakraborty1,
  5. Scott Goates1,
  6. Menghua Luo1,
  7. Jeffrey I Mechanick2
  1. 1Research and Development, Abbott Nutrition, Columbus, Ohio, USA
  2. 2Divisions of Cardiology and Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, Mount Sinai School of Medicine, New York, USA
  1. Correspondence to Dr Vikkie A Mustad; vikkie.mustad{at}abbott.com

Abstract

Objective The aim of this study was to examine the impact of pre-existing malnutrition on survival and economic implications in elderly patients with diabetes.

Research design and methods A retrospective observational study was conducted to examine the impact of malnutrition with or without other significant health conditions on survival time and healthcare costs using the Centers for Medicare and Medicaid Services (CMS) data from 1999 to 2014 for beneficiaries with a confirmed first date of initial diagnosis of diabetes (n=15 121 131). The primary outcome was survival time, which was analyzed using all available data and after propensity score matching. Healthcare utilization cost was a secondary outcome.

Results A total of 801 272 beneficiaries were diagnosed with malnutrition. The analysis on propensity score-matched data for the effect of common conditions on survival showed that the risk for death in beneficiaries with diabetes increased by 69% in malnourished versus normo-nourished (HR, 1.69; 99.9% CI 1.64 to 1.75; P<0.0001) beneficiaries. Malnutrition increased the risk for death within each of the common comorbid conditions including ischemic heart disease (1.63; 1.58 to 1.68), chronic obstructive pulmonary disorder (1.60; 1.55 to 1.65), stroke or transient ischemic attack (1.57; 1.53 to 1.62), heart failure (1.54; 1.50 to 1.59), chronic kidney disease (1.50; 1.46 to 1.55), and acute myocardial infarction (1.47; 1.43 to 1.52). In addition, the annual total spending for the malnourished beneficiaries was significantly greater than that for the normo-nourished beneficiaries ($36 079 vs 20 787; P<0.0001).

Conclusions Malnutrition is a significant comorbidity affecting survival and healthcare costs in CMS beneficiaries with diabetes. Evidence-based clinical decision pathways need to be developed and implemented for appropriate screening, assessment, diagnosis and treatment of malnourished patients, and to prevent malnutrition in normo-nourished patients with diabetes.

  • retrospective study
  • malnutrition
  • mortality
  • health care utilization

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors The authors meet the criteria for authorship recommended by the International Committee of Medical Journal Editors and take full responsibility for all content in the manuscript and all editorial decisions. Concept and development and design of study: NA, SG, YC, VAM; data collection, analysis and interpretation: NA, SG, YC, VAM, SC, ML, JIM; development and review of the manuscript: NA, SG, YC, VAM, ML, JIM; finalization and approval of the manuscript: NA, SG, YC, VAM, SC, ML, JIM; guarantor of the study: NA.

  • Funding This study was sponsored by Abbott Nutrition.

  • Competing interests All except JIM are shareholders and employees of Abbott. JIM has served in the advisory board of Abbott Nutrition and has been a compensated advisor of Abbott Nutrition.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Presented at 77th Annual ADA Scientific Sessions, poster, health care delivery–economics, 173-LB, 2017.